The IMPACT HTA WP7 developed a number of frameworks and tools using multi-criteria value methods (MCDA) to support decision-making for HTA. Visit the IMPACT HTA website to read the published summaries of the research carried out
https://t.co/EKlshdlKxm
The iMPACT HTA final conference that took place in June 2021, provides an overview of the project's results and all the tools produced. Please visit https://t.co/rwib7IRz5L to watch the video, see the presentations and read the summary report.
The European Healthcare and Social Cost Database (EU HCCD) provides a common dataset of international costs that allows analysis of variations in costs and health economic evaluations within/across countries.
Access the database https://t.co/n7F80tZcb9
Our new article "Accounting for unobservable preference heterogeneity and evaluating alternative anchoring approaches to estimate country-specific EQ-5D-Y value sets: A case study using Spanish preference data" has just been published. https://t.co/9wPnRjBoo8
iMPACT HTA WP6 has published a new article on "the use of nonrandomized evidence to estimate treatment effects in health technology assessment".
https://t.co/1gwV3MYAiB
Consideration of quality of life in the health technology assessments of rare disease treatments.
New article from iMPACT HTA's Appraisal of Orphan Medicinal Products work package.
https://t.co/8GIxZb01of
iMPACT HTA is very proud to share the DICE platform based on Discretely Integrated Condition Event simulation to model health benefits and treatment costs during CEA modelling.
Access:https://t.co/oIN0Ah9J1c
Driving health technologies towards performance: a contextualisation within the hospital setting.
Access our new publication on hospital-based HTAs here: https://t.co/Ov3DOKpC1C
The IMPACT HTA Consortium has successfully concluded its 2nd research meeting, hosted by AOTMiT in Warsaw on 10-11 January. For updates on research https://t.co/C0RF1AscXX